Identification of ATM1 gene involved in antifungal resistance based on CRISPR/Cas9 technology in Cryptococcus gattii
Medical Mycology · 2025
DOI: 10.1093/mmy/myaf061 ↗Kurz gefasst
Fachartikel in der Zeitschrift Medical Mycology, 2025. Verfasst von Jiahui Huang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Cell Proliferation and Regulation Biology, Ministry of Education, College of Life Sciences, Beijing Normal University, Beijing 1008…. Hauptthemen laut MEDLINE: Cryptococcus gattii, CRISPR-Cas Systems, Drug Resistance, Fungal, Antifungal Agents. Die Arbeit nennt 51 Literaturangaben. Gefördert von: National Key Research and Development Program of China, National Foundation of Science of China.
Abstract (Originalsprache)
Cryptococcus gattii is a fungal pathogen that poses significant threats to human health, affecting both immunocompromised and immunocompetent individuals. Treatment of C. gattii infections typically involves the use of antifungal agents, such as azoles. However, the increasing emergence of antifungal resistance in C. gattii is a growing concern, highlighting the critical need for novel therapeutic strategies. In our previous study, we identified a mitochondrial ATP-binding cassette (ABC) transporter, Atm1, as potentially involved in antifungal resistance in C. gattii through transcriptome sequencing, but its function remains unclear and requires additional confirmation and investigation. In this study, we developed a “suicide” clustered regularlyinterspaced short palindromic repeats-CRISPR-associated protein 9 system in C. gattii, based on the system used in C. neoformans, and successfully validated its functionality by targeting the ADE2 gene. We subsequently generated C. gattii mutants lacking ATM1 and assessed their growth under various stress conditions. Our data suggest that Atm1 is involved in the iron–sulfur cluster biosynthesis process. Besides, disruption of ATM1 resulted in various growth impairments, including reduced stress tolerance, impaired capsule formation, and diminished virulence. Importantly, we observed compromised antifungal drug resistance in the atm1∆ mutant and performed RNA sequencing-based transcriptome analysis and gene ontology analysis with and without antifungal treatment for further investigation. In conclusion, our findings indicate that ATM1 plays a role in iron homeostasis and is critical for antifungal resistance in C. gattii, offering new insights into potential drug development strategies for the clinical treatment of cryptococcosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Key Laboratory of Cell Proliferation and Regulation Biology, Ministry of Education, College of Life Sciences, Beijing Normal University, Beijing 100875, China.
- Department of Respiratory and Critical Care, Emergency and Critical Care Medical Center, Beijing Shijitan Hospital, Capital Medical University, Beijing 100038, China.
- School of Life Science and Technology, ShanghaiTech University, Shanghai 200032, China; Shanghai Clinical Research and Trial Center, Shanghai 201210, China.
ORCID-Profile: Jiahui Huang, Xuelei Zang
Förderung
- National Key Research and Development Program of China
- National Foundation of Science of China
Zitieren
APA
Huang, J., Zhao, X., Zang, X., Jin, Z., Zhang, X., Huang, Y., Zhang, L., Xue, X., & Zhang, P. (2025). Identification of ATM1 gene involved in antifungal resistance based on CRISPR/Cas9 technology in Cryptococcus gattii. Medical Mycology. https://doi.org/10.1093/mmy/myaf061
Vancouver
Huang J, Zhao X, Zang X, Jin Z, Zhang X, Huang Y, et al. Identification of ATM1 gene involved in antifungal resistance based on CRISPR/Cas9 technology in Cryptococcus gattii. Medical Mycology. 2025. doi:10.1093/mmy/myaf061
BibTeX
@article{Huang2025,
author = {Huang, Jiahui and Zhao, Xuan and Zang, Xuelei and Jin, Ziyi and Zhang, Xueqing and Huang, Yemei and Zhang, Liye and Xue, Xinying and Zhang, Ping},
title = {Identification of ATM1 gene involved in antifungal resistance based on CRISPR/Cas9 technology in Cryptococcus gattii},
journal = {Medical Mycology},
year = {2025},
doi = {10.1093/mmy/myaf061}
}
EUVIMED